![Frontiers | Development and Validation of a Novel Risk Stratification Model for Cancer-Specific Survival in Diffuse Large B-Cell Lymphoma Frontiers | Development and Validation of a Novel Risk Stratification Model for Cancer-Specific Survival in Diffuse Large B-Cell Lymphoma](https://www.frontiersin.org/files/Articles/582567/fonc-10-582567-HTML-r1/image_m/fonc-10-582567-g007.jpg)
Frontiers | Development and Validation of a Novel Risk Stratification Model for Cancer-Specific Survival in Diffuse Large B-Cell Lymphoma
![Diffuse Large B-Cell Lymphoma Risk Score Calculator: A Tool To Accurat" by Santosh Khanal, Arjun Gampala et al. Diffuse Large B-Cell Lymphoma Risk Score Calculator: A Tool To Accurat" by Santosh Khanal, Arjun Gampala et al.](https://scholarlyexchange.childrensmercy.org/research_month2022/1007/preview.jpg)
Diffuse Large B-Cell Lymphoma Risk Score Calculator: A Tool To Accurat" by Santosh Khanal, Arjun Gampala et al.
![Relapsed/Refractory International Prognostic Index (R/R‐IPI): An international prognostic calculator for relapsed/refractory diffuse large B‐cell lymphoma - Maurer - 2021 - American Journal of Hematology - Wiley Online Library Relapsed/Refractory International Prognostic Index (R/R‐IPI): An international prognostic calculator for relapsed/refractory diffuse large B‐cell lymphoma - Maurer - 2021 - American Journal of Hematology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/55590ce0-5280-4f9f-9092-62815b543c03/ajh26149-fig-0002-m.jpg)
Relapsed/Refractory International Prognostic Index (R/R‐IPI): An international prognostic calculator for relapsed/refractory diffuse large B‐cell lymphoma - Maurer - 2021 - American Journal of Hematology - Wiley Online Library
![International prognostic indices in diffuse large B-cell lymphoma: a comparison of IPI, R-IPI, and NCCN-IPI - ScienceDirect International prognostic indices in diffuse large B-cell lymphoma: a comparison of IPI, R-IPI, and NCCN-IPI - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0006497120619760-gr1.jpg)
International prognostic indices in diffuse large B-cell lymphoma: a comparison of IPI, R-IPI, and NCCN-IPI - ScienceDirect
![PDF) Surgery shows survival benefit in patients with primary intestinal diffuse large B-cell lymphoma: A population-based study PDF) Surgery shows survival benefit in patients with primary intestinal diffuse large B-cell lymphoma: A population-based study](https://i1.rgstatic.net/publication/351273377_Surgery_shows_survival_benefit_in_patients_with_primary_intestinal_diffuse_large_B-cell_lymphoma_A_population-based_study/links/609faa37299bf147699a9032/largepreview.png)
PDF) Surgery shows survival benefit in patients with primary intestinal diffuse large B-cell lymphoma: A population-based study
![Favourable outcomes for high-risk diffuse large B-cell lymphoma (IPI 3–5) treated with front-line R-CODOX-M/R-IVAC chemotherapy: results of a phase 2 UK NCRI trial - Annals of Oncology Favourable outcomes for high-risk diffuse large B-cell lymphoma (IPI 3–5) treated with front-line R-CODOX-M/R-IVAC chemotherapy: results of a phase 2 UK NCRI trial - Annals of Oncology](https://www.annalsofoncology.org/cms/asset/bd4dbbaa-3abc-4fed-be72-9f83c6b1c604/gr1.jpg)